Featured Products related products

Cat No.	Product Name	CAS No.	Product description
V0725	Telaprevir ( LY-570310; VX950; MP-424)	402957-28-2	Telaprevir (also known as LY570310; VX-950; MP424; trade names: Incivek; Incivo), a marketed medication for HCV treatment, is a selective, and reversible peptidomimetic inhibitor of HCV NS3-4A serine protease with an IC50 of 0.35 μM.
V19288	DCKA	131123-76-7	5,7-Dichlorokynurenic acid (5,7-DCKA) is a selective NMDA receptor glycine site competitive antagonist (inhibitor) with a Kb of 65 nM.
V0630	Pexidartinib (PLX3397; Turalio; CML261; FP113)	1029044-16-3	Pexidartinib (formerly PLX-3397; CML-261;FP-113; trade name Turalio) is an orally bioavailable and multi-targeted RTK (receptor tyrosine kinase) inhibitor of CSF-1R, Kit, and Flt3 with potential antineoplastic activity.
V0522	Semaxanib (SU-5416)	204005-46-9	Semaxanib (also known as SU5416) is a novel, potent and selective VEGFR (Flk-1/KDR) inhibitor with potential anticancer activity.
V0415	Apabetalone (RVX-08, RVX-000222)	1044870-39-4	Apabetalone (also known as RVX-208, RVX000222) is a novel and potent inhibitor of BET (Bromodomain and Extra-Terminal) bromodomain (BD) with potential anti-inflammatory activity and the potential to be used in the treatment of cardiovascular diseases.
V39377	DBCO-PEG3-TCO		DBCO-PEG3-TCO is a non-cleavable (non-degradable) ADC linker containing 3 Polyethylene glycol (PEG) units, which may be utilized to prepare Antibody-drug conjugates (ADC).
V32889	DPN	1428-67-7	DPN (Diarylpropionitrile) is a non-steroidal estrogen receptor ERβ selective ligand with EC50 of 0.85 nM.
V47750	15-Nor-14-oxolabda-8(17),12E-Diene-18-oic acid	1039673-32-9	15-Nor-14-oxolabda-8(17),12E-Diene-18-oic acid (compound 9) is a compound extracted from Chloranthus spicatus.
V30349	Echinocystic acid	510-30-5	Echinocystic acid is a naturally occurringpentacyclic triterpene found in the fruits of Gleditsia sinensis Lam with antioxidant, anti-inflammatory and anticancer pactivities.
V20571	Enmenol	28957-06-4	Enmenol is a novel and potent bioactive compound
V0342	Tofacitinib (CP690550; tasocitinib)	477600-75-2	Tofacitinib (also known as tasocitinib or CP-690550, sold under the brandXeljanz),is a novel and potent inhibitor of JAK3 (Janus-Associated kinase) with potential anti-inflammatory activity.
V0390	EPZ015666 (GSK3235025)	1616391-65-1	EPZ015666 (GSK-3235025), an analog ofEPZ-015866, is a potent, selective and orally bioavailable inhibitor of PRMT5 (protein arginine methyltransferase) with antineoplastic activity.
V52787	Carbazole-d8 (咔唑-d8)	38537-24-5	Carbazole-d8 is the deuterated form of Carbazole (HY-D0204).
V35046	Ditiocarb (Diethyldithiocarbamic acid)	147-84-2	Ditiocarb (Diethyldithiocarbamic acid) is a copper reagent that reacts with Cu2+ solution to form a complex, which increases the copper replacement precipitation rate.
V0245	Acadesine (AICAR; NSC-105823)	2627-69-2	Acadesine (also known as NSC105823,AICA-riboside, and AICAR) is a novel and potent AMPK (AMP-activated protein kinase) activatorwith potential antitumor and antidiabetic activity.
V0729	Ritonavir (ABT-538; Norvir)	155213-67-5	Ritonavir (previously known as ABT-538; A-84538; RTV; ABT538, trade name: Norvir) is a L-valine derivative and potent inhibitor of HIV-1 protease used to treat HIV infection and AIDS. It is widely used as a booster for other protease inhibitors/PIs such as lopinavir, and makes them work better.
V0633	GW2580 (SC203877)	870483-87-7	GW2580 (also known as SC-203877)is a novel, potent, selective, and orally bioavailable c-Fms kinaseCSF-1R inhibitor with potential antineoplastic activity.
V0572	Imatinib Mesylate (STI571; Gleevec; Glivec)	220127-57-1	Imatinib Mesylate (also known as STI571 mesylate; trade names: Gleevec or Glivec), the mesylate salt of imatinib, is an orally bioavailable,potent,multi-kinase inhibitor of v-Abl, c-Kit and PDGFR with potential antitumor activity.
V2967	PF-05089771	1235403-62-9	PF-05089771 (PF05089771) is a potent and subtype selective NaV1.7 inhibitor (IC50 = 11 nM) and Nav1.8voltage-gated sodium channelblocker with the potential to be used in the treatment of chronic neuropathic pain.
V0035	Pomalidomide (CC4047 or actimid)	19171-19-8	Pomalidomide (formerly also known as CC-4047 or actimid), an analog of thalidomide, is a potent andorally bioavailable immunomodulatory molecule with antineoplastic activity.